Ventripoint Diagnostics has earned CE mark approval in Europe to add a 2D ultrasound imaging application to its VMS platform for right-heart evaluation. The NRV application lets clinicians examine the right ventricle in patients who may have additional heart conditions, but don't have pulmonary hypertension or significant congenital heart defects.
EU widens approval for Ventripoint's heart imaging platform
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||